UK’s NICE publishes a Medtech innovation briefing on PICO™ for the prophylactic use in surgically closed incisions to reduce surgical site complications
The UK’s National Institute for Health and Care Excellence (NICE) has published a Medtech innovation briefing (MIB) on the use of Smith & Nephew’s PICO single-use negative pressure wound therapy (sNPWT).
The MIB has described the prophylactic use of PICO as a potential alternative to standard surgical dressings in the prevention of surgical site complications (SSCs). This is the first and only MIB published by NICE on an NPWT device for preventing SSCs.
As part of the MIB, NICE conducted a thorough review of the published and peer-reviewed data from a variety of meta-analyses and randomised controlled trials (RCTs). The effectiveness of PICO in reducing SSCs has been examined in 10 RCTs and multiple observational studies.
The PICO dressing has a proprietary AIRLOCK™ Technology that uniformly and consistently delivers NPWT across a surgical incision and the surrounding zone of injury generated naturally by the incision itself. This proprietary feature is designed to help reduce the risk of wound complications by reducing post-operative fluid, swelling and associated tension around a closed surgical incision compared with standard dressings. The combination of these actions helps reduce the risk of surgical wound dehiscence and SSIs, the 2 most common SSCs.
“Today we are delighted to see the NICE MIB support for the prophylactic use of PICO as an effective alternative for clinicians who look to reduce their rates of surgical site complications. This will provide the NHS and other international healthcare systems with the confidence to use PICO for their at-risk patients and procedures,” said Paolo Di Vincenzo, Smith & Nephew’s SVP of Advanced Wound Management. “PICO has shown significant clinical results in reducing life-threatening infections on closed surgical incisions, which has contributed significantly to improved patient outcomes, in a cost-effective portable solution.”
Read more about NICE’s finding here: http://www.smith-nephew.com/PICOMIB